Skip to main content

Revance Therapeu Shares Down 21.9% Since SmarTrend's Sell Call (RVNC)

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on February 5th, 2018 at $30.60. In approximately 8 months, Revance Therapeu has returned 21.93% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.